Arpeggio Bio Company

Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.
Technology: Biotechnology, Machine Learning
Industry: Early Drug Development
Headquarters: Boulder, Colorado, United States
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 6
Total Funding: 3350000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-01-15
Last Funding Type: Seed

Visit Website
https://twitter.com/ArpeggioBio
Register and Claim Ownership